Rafat Fields’ Post

On this episode of Healthcare Americana, Christopher Habig is joined by president and founder of The Market Institute, Charles Sauer. Charles shares the role of profit motive in healthcare, the concept of opportunity cost in patient care, and the impact of policy decisions on market freedom and innovation. If you've ever wondered how policy decisions shape the healthcare industry, this episode is for you. Click here to access the interview: https://lnkd.in/g5GUx9KF

HCAA members, don't forget to register for the webinar titled "The New, Ethically Transparent World of Healthcare"! Join Mark Galvin to learn how to leverage price transparency compliance and gain invaluable insights into the evolving landscape of the healthcare ecosystem. #pricetransparency #HCAA #healthcare

Today we will be hosting our virtual Healthcare Insights Summit 2024. At this summit, we will unpack key developments and insights in the healthcare industry and how these impact the open scheme market, focusing on Momentum Medical Scheme and Momentum Health4Me. #MoreHealth

So, I am back from JPM Healthcare conference in SanFran.  It was a crazy week and a great experience. My 5 takeaways: (1) It is THE place to be for Pharma / Biotech partnering (2) Specifically for publicly traded organisations, presenting your company at the conference is a must to enforce your relevancy (3) The action is outside of the actual conference - majority of people don’t attend the conference but rather meet for business development, investment, or company analysis (4) Getting invited and attending the right evening receptions is even more critical than formal meetings. I had five receptions in one evening - could only make 3 of the 5 but they were worth it. (5) And MOST importantly, wear comfortable walking shoes and bring a good umbrella as you are moving between all the various hotels in central SanFran as you race to get to your next meeting. As mentioned previously, our BenevolentAI's Chairman & acting CEO, Francois Nader presented at the conference and did a fabulous job. He even mentioned my name as the Chief Revenue Officer in spearheading our way forward - quite an honour! The link to the recording is below.  In my PoV it is worth 20 minutes of your time. However, if you don't have time here is my recap: We are at the intersection of Pharma & Tech and  a pioneer & leader in AI-augmented drug discovery, enabled by the Benevolent Platform. We stand above our competition of AI in drug discovery as not only have we been doing it for 10 years, but we are also one of the rare platforms that has validated our approach via three ways : (1) Successful collaborations with AstraZeneca with TargetID and most recently Merck Healthcare KGaA with Chemistry. For AstraZeneca the products are in the pipeline and they're real. (2) We leveraged our indication expansion capabilities to identify Eli Lilly and Company's rheumatoid arthritis drug Olumiant (baricitinib) as a potential treatment for COVID-19, which received an emergency use authorisation from the US FDA in 2020; full approval in May 2022. (3) Our platform has generated 5 wholly owned products in a pipeline that looks like a traditional Biotech. Our lead asset BEN-8744 is an oral PDE10 inhibitor in Phase I which is a potential first-in-class option for ulcerative colitis. Our Business model offers multiple routes for value creation. In addition to our high potential R&D pipeline and our leading E2E Drug Discovery solutions mentioned above, we have a new expansion opportunity through suite of Knowledge Exploration tools that acting as a co-pilot for scientists, leverages bio-specific natural language processing (NLP) and large language models (LLM) to surface data, perform analysis, and give scientific recommendations to drive new insights and increase productivity. So, as you can see from above, this is a very exciting time for BenevolentAI and I am thrilled to be part of the journey! #JPM2024 #drugdiscovery #aidrugdiscovery #generativeai #researchanddevelopment

Announcing the first ever class of Modern Healthcare's 40 Under 40! Read the profiles of the exceptional young executives we selected and learn about their indelible impact on their organizations, the patients and communities they serve and the future of healthcare. View the Honorees: https://ow.ly/l9FX50QAHVa

In this blog, Dr Nicola Hutchinson, Chief Executive for HI NENC, shares some of the homegrown innovations that are having a positive impact on patients in the North East and North Cumbria. Read here and find out how we can continue to celebrate and inspire healthcare innovators in the region 👉 bit.ly/3JR1EQN

Discover the disruptive origin story of our firm! 👀⁠ ⁠ Watch our most recent Healthcare Disruptors Series episode featuring Jeff Cohen and Autumn Piccolo now on YouTube!⁠ ⁠ #floridahealthcarelawfirm #floridahealthattorney #floridahealthcarelaw #healthcaredisruptorsseries

Kicking off our first session at #HITLABSymposium! Join us as experts discuss innovative solutions to overcome barriers in healthcare through digital pathways. #HealthInnovation #DigitalHealth

Interested in learning what it takes for your company to partner with health systems? Join us on April 26th for a live discussion featuring a fantastic panel of experts! Gain valuable insights into partnering with health systems and ask your questions in real time. Don't miss out on this opportunity to connect with industry leaders! #heathcaretransformation #healthsystems #caretransformationstudio

Dive into real-world scenarios and actionable insights with Chris at the 2024 Annual WALA Conference! Learn how to lead with empathy, accountability, and grace to create a thriving healthcare environment. Don't miss out – see you tomorrow morning! #PostAcuteLeaders #LegacyLeadership #WALAConference